Emerge Invest successfully advised the Sefrioui Group in the acquisition of Afric-Phar, Pharmis and Partner Lab laboratories.

Emerge Invest was the exclusive financial advisor of Pharma Capital (Sefrioui Group) throughout all stages of this major acquisition, from origination to closing on January 7, 2025.

The Afric-Phar laboratory, with its two subsidiaries Pharmis and Partner Lab, constitutes one of the leading Moroccan pharmaceutical groups.

Through this acquisition, the Sefrioui Group, already present in real estate and cement, makes its entry into the pharmaceutical sector.

To find out more: LeMatin.ma